Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Profound Medical Corp. PROF

Set alert

Price alert · PROF

All alert types
6.73 USD +0.16 +2.44%

At close · Nov 2

6.73 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
6.73 × 2
Ask
6.75 × 2
6.51 Day range 7.11
4.80 52-week range 8.95
YTD
-14.49%
1 year
+10.87%
Open
6.51
Prev close
6.57
Mkt cap
245.92M
Vol
290.36K
Avg vol
192.57K
EPS
-0.99
P/E
0.00
Div yield
0.00%
More statistics
Low
6.51
High
7.11
Forward P/E
-7.95
Beta
0.83
Short ratio
7.87
Inst. own
35.99%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
7.73
200-d avg
8.29
1y target
15.30

1M chart

Chart tools
Interval
1m5m15m30m

Signals (9)
NameDateAgo
SMA: BullishOct 30, 20263 days ago
MACD: Buy SignalOct 30, 20263 days ago
SMA: BullishOct 29, 20264 days ago
MACD: Sell SignalOct 20, 20261 week ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BullishOct 8, 20263 weeks ago
SMA: BullishOct 8, 20263 weeks ago
SMA: BearishOct 7, 20263 weeks ago

Financial health

Altman Z-Score

9.68 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -5.5×
FY 2016: -3.3×FY 2017: -5.0×FY 2018: -8.7×FY 2019: -10.2×FY 2020: -16.4×FY 2021: -7.5×FY 2022: -7.9×FY 2023: -6.3×FY 2024: -7.0×FY 2025: -5.5×
FY 2016 5y median -7.0× FY 2025
P/S 14.5×
FY 2016: 0.0×FY 2017: 15.3×FY 2018: 69.6×FY 2019: 37.8×FY 2020: 48.7×FY 2021: 33.4×FY 2022: 34.0×FY 2023: 25.0×FY 2024: 18.3×FY 2025: 14.5×
FY 2016 5y median 25.0× FY 2025
P/B 2.6×
FY 2016: 4.9×FY 2017: 6.7×FY 2018: 5.0×FY 2019: 11.0×FY 2020: 3.7×FY 2021: 2.9×FY 2022: 4.4×FY 2023: 5.8×FY 2024: 3.1×FY 2025: 2.6×
FY 2016 5y median 3.1× FY 2025
P/FCF -6.1×
FY 2016: -4.7×FY 2017: -6.2×FY 2018: -9.9×FY 2019: -10.2×FY 2020: -17.0×FY 2021: -10.0×FY 2022: -8.8×FY 2023: -8.0×FY 2024: -7.9×FY 2025: -6.1×
FY 2016 5y median -8.0× FY 2025
EV/EBITDA -3.9×
FY 2016: -2.8×FY 2017: -4.3×FY 2018: -6.3×FY 2019: -12.3×FY 2020: -14.0×FY 2021: -5.7×FY 2022: -7.1×FY 2023: -6.0×FY 2024: -5.3×FY 2025: -3.9×
FY 2016 5y median -5.7× FY 2025
EV/Sales 9.9×
FY 2016: 0.0×FY 2017: 14.3×FY 2018: 62.4×FY 2019: 36.8×FY 2020: 37.4×FY 2021: 23.9×FY 2022: 28.2×FY 2023: 22.4×FY 2024: 13.4×FY 2025: 9.9×
FY 2016 5y median 22.4× FY 2025
FCF Yield -16.4%
FY 2016: -21.4%FY 2017: -16.2%FY 2018: -10.1%FY 2019: -9.8%FY 2020: -5.9%FY 2021: -10.0%FY 2022: -11.4%FY 2023: -12.6%FY 2024: -12.6%FY 2025: -16.4%
FY 2016 5y median -12.6% FY 2025

Profitability

Gross Margin 70.8%
FY 2016: 0.0%FY 2017: 38.2%FY 2018: 31.7%FY 2019: 57.3%FY 2020: 47.6%FY 2021: 43.0%FY 2022: 45.2%FY 2023: 60.9%FY 2024: 65.9%FY 2025: 70.8%
FY 2016 5y median 60.9% FY 2025
Operating Margin -256.3%
FY 2016: 0.0%FY 2017: -349.7%FY 2018: -776.0%FY 2019: -357.1%FY 2020: -258.3%FY 2021: -440.7%FY 2022: -480.9%FY 2023: -397.5%FY 2024: -309.6%FY 2025: -256.3%
FY 2016 5y median -397.5% FY 2025
Net Margin -264.4%
FY 2016: 0.0%FY 2017: -389.4%FY 2018: -797.9%FY 2019: -364.7%FY 2020: -296.0%FY 2021: -446.7%FY 2022: -429.1%FY 2023: -396.8%FY 2024: -260.4%FY 2025: -264.4%
FY 2016 5y median -396.8% FY 2025
ROE -47.6%
FY 2016: -110.0%FY 2017: -169.8%FY 2018: -57.3%FY 2019: -105.8%FY 2020: -22.2%FY 2021: -38.1%FY 2022: -55.1%FY 2023: -91.5%FY 2024: -43.8%FY 2025: -47.6%
FY 2016 5y median -47.6% FY 2025
ROIC -22.7%
FY 2016: -96.4%FY 2017: -92.8%FY 2018: -37.6%FY 2019: -57.2%FY 2020: -18.8%FY 2021: -36.6%FY 2022: -52.7%FY 2023: -71.3%FY 2024: -47.9%FY 2025: -22.7%
FY 2016 5y median -47.9% FY 2025
ROA -22.4%
FY 2016: -68.9%FY 2017: -86.1%FY 2018: -32.9%FY 2019: -50.6%FY 2020: -20.7%FY 2021: -35.4%FY 2022: -44.5%FY 2023: -65.0%FY 2024: -37.7%FY 2025: -22.4%
FY 2016 5y median -37.7% FY 2025

Growth (YoY)

Revenue 61.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -61.0%FY 2019: 118.5%FY 2020: 75.0%FY 2021: -5.9%FY 2022: -2.8%FY 2023: 7.8%FY 2024: 41.2%FY 2025: 61.1%
FY 2016 FY 2025
Operating Income -33.4%
FY 2016: -34.5%FY 2017: -5.6%FY 2018: 13.5%FY 2019: -0.5%FY 2020: -26.6%FY 2021: -60.6%FY 2022: -6.1%FY 2023: 10.9%FY 2024: -10.0%FY 2025: -33.4%
FY 2016 FY 2025
EPS (diluted) -33.6%
FY 2016: 43.1%FY 2017: 37.9%FY 2018: 37.7%FY 2019: 8.6%FY 2020: 10.1%FY 2021: -20.0%FY 2022: 8.0%FY 2023: 2.2%FY 2024: 20.7%FY 2025: -33.6%
FY 2016 FY 2025
Free Cash Flow -66.5%
FY 2016: -129.0%FY 2017: -5.0%FY 2018: -10.3%FY 2019: -15.0%FY 2020: -35.5%FY 2021: -9.7%FY 2022: -12.4%FY 2023: 12.4%FY 2024: -3.7%FY 2025: -66.5%
FY 2016 FY 2025

Financial Health

Current Ratio 12.5×
FY 2016: 4.5×FY 2017: 1.6×FY 2018: 6.6×FY 2019: 2.8×FY 2020: 20.3×FY 2021: 18.6×FY 2022: 14.8×FY 2023: 6.6×FY 2024: 10.5×FY 2025: 12.5×
FY 2016 5y median 12.5× FY 2025
Quick Ratio 11.2×
FY 2016: 4.5×FY 2017: 1.5×FY 2018: 5.9×FY 2019: 2.3×FY 2020: 19.2×FY 2021: 16.8×FY 2022: 12.9×FY 2023: 5.5×FY 2024: 9.6×FY 2025: 11.2×
FY 2016 5y median 11.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.8×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.8×
FY 2016: 0.7×FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.3×FY 2020: 4.2×FY 2021: 2.3×FY 2022: 1.4×FY 2023: 0.7×FY 2024: 1.9×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Interest Coverage 0.0×
FY 2016: -26.4×FY 2017: -16.0×FY 2018: -19.6×FY 2019: -14.4×FY 2020: -34.7×FY 2021: -456×FY 2022: -192×FY 2023: -37.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median -37.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31